British drugmaker GSK said on Friday the U.S. Food and Drug Administration has expanded the approved age range for its respiratory syncytial virus vaccine, Arexvy, to…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/gsk-gets-us-fda-approval-expanded-use-rsv-vaccine-2026a10007tj?src=rss
Author :
Publish date : 2026-03-13 11:03:00
Copyright for syndicated content belongs to the linked Source.